Skip to main content
SpringerLink
Log in

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma

A Southwest Oncology Group study

  • Phase II Studies
  • Brief Report
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brown T, Koeller J, Beougher K, Golando J, Bonnem E, Von Hoff D: A phase I clinical trial of recombinant DNA gamma Interferon (GIFN). (Abstr) Proc Am Soc Clin Oncol 5: 225, 1986

    Google Scholar 

  2. Dianzani F, Salter L, Fleischman Jr WR, Zucca M: Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med 159: 94–97, 1978

    Google Scholar 

  3. Garnick MB, Reich SD, Maxwell B, Coval-Goldsmith S, Richie J, Rudnick SA: Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma. J Urol 139: 251–255, 1988

    Google Scholar 

  4. Muss HB: The role of biologic response modifiers in metastatic renal cell carcinoma. Semin Oncol 15: 30–34, 1988

    Google Scholar 

  5. Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU: Phase II studies of recombinant human gamma in metastatic renal cell carcinoma. J Biol Resp Mod 6: 20–27, 1987

    Google Scholar 

  6. Koise K: Phase II study of recombinant human Interferon gamma (S-6810) on renal cell carcinoma. Summary of two collaborative studies. Cancer 60: 929–933, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Oklahoma Health Sciences Center, USA

    J. Philip Kuebler & Craig L. Reitz

  2. Southwest Oncology Group Statistical Center, Seattle

    Phyllis J. Goodman

  3. University of Texas Health Sciences Center, San Antonio

    Thomas D. Brown

  4. University of Colorado, USA

    E. David Crawford

  5. University Hospital, St. Louis

    William A. Knight III

  6. Wayne State University Medical Center, USA

    Julie A. Kish

Authors
  1. J. Philip Kuebler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phyllis J. Goodman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas D. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. David Crawford
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Craig L. Reitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. William A. Knight III
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Julie A. Kish
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuebler, J.P., Goodman, P.J., Brown, T.D. et al. Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. Invest New Drugs 8, 307–309 (1990). https://doi.org/10.1007/BF00171843

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00171843

Key words

Search

Navigation